Skip to main content
TipRanks
Go Ultimate75% OFF

Yuyu Pharma, Inc. (000220) Ratios

Yuyu Pharma, Inc. Ratios

KR:000220's free cash flow for Q3 2026 was ₩-2.53B. For the 2026 fiscal year, KR:000220's free cash flow was decreased by ₩-6.64B and operating cash flow was ₩4.12B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.641.582.031.503.29
Quick Ratio0.930.981.150.882.45
Cash Ratio0.490.650.610.401.67
Solvency Ratio0.210.20-0.020.010.06
Operating Cash Flow Ratio0.270.390.01-0.100.15
Short-Term Operating Cash Flow Coverage0.590.760.02-0.170.45
Net Current Asset Valueâ‚© 29.88Bâ‚© 29.32Bâ‚© 23.74Bâ‚© 24.53Bâ‚© 34.59B
Leverage Ratios
Debt-to-Assets Ratio0.130.160.200.200.20
Debt-to-Equity Ratio0.220.270.350.340.32
Debt-to-Capital Ratio0.180.210.260.250.24
Long-Term Debt-to-Capital Ratio0.000.000.110.010.19
Financial Leverage Ratio1.601.661.771.671.55
Debt Service Coverage Ratio0.500.530.170.070.47
Interest Coverage Ratio1.983.630.140.271.22
Debt to Market Cap0.360.450.390.370.31
Interest Debt Per Share2017.812277.852261.402524.452590.50
Net Debt to EBITDA-0.07-0.431.813.95-1.76
Profitability Margins
Gross Profit Margin38.29%38.83%35.37%38.39%39.20%
EBIT Margin7.82%9.92%-0.55%-0.89%1.55%
EBITDA Margin11.80%14.17%3.54%2.45%5.44%
Operating Profit Margin7.82%8.79%0.27%0.50%2.29%
Pretax Profit Margin6.73%7.50%-3.97%-2.74%-0.33%
Net Profit Margin5.79%6.55%-5.23%-3.19%-0.80%
Continuous Operations Profit Margin6.47%7.73%-4.04%-3.19%-0.80%
Net Income Per EBT85.99%87.34%131.95%116.14%240.19%
EBT Per EBIT86.06%85.36%-1492.89%-550.83%-14.44%
Return on Assets (ROA)3.93%4.20%-3.62%-2.27%-0.48%
Return on Equity (ROE)6.31%6.96%-6.40%-3.79%-0.74%
Return on Capital Employed (ROCE)7.43%8.17%0.25%0.53%1.63%
Return on Invested Capital (ROIC)6.02%6.63%0.21%0.41%1.53%
Return on Tangible Assets3.99%4.26%-3.70%-2.31%-0.49%
Earnings Yield10.89%11.96%-7.23%-4.26%-0.74%
Efficiency Ratios
Receivables Turnover7.096.756.606.335.92
Payables Turnover4.468.608.105.407.83
Inventory Turnover2.062.112.012.152.79
Fixed Asset Turnover1.511.481.691.711.44
Asset Turnover0.680.640.690.710.60
Working Capital Turnover Ratio3.742.993.282.752.01
Cash Conversion Cycle146.92184.74191.98160.00145.94
Days of Sales Outstanding51.5154.0955.3357.6661.63
Days of Inventory Outstanding177.25173.12181.72169.91130.93
Days of Payables Outstanding81.8442.4645.0867.5746.62
Operating Cycle228.76227.21237.06227.57192.56
Cash Flow Ratios
Operating Cash Flow Per Share968.391541.7522.68-375.68282.51
Free Cash Flow Per Share470.961090.43-252.51-711.47-140.50
Dividend Paid and CapEx Coverage Ratio1.582.800.06-0.820.52
Capital Expenditure Coverage Ratio1.953.420.08-1.120.67
Operating Cash Flow Coverage Ratio0.580.740.01-0.160.12
Operating Cash Flow to Sales Ratio0.110.190.00-0.040.04
Free Cash Flow Yield10.43%24.20%-4.72%-11.37%-1.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio9.189.62-13.82-23.45-135.44
Price-to-Sales (P/S) Ratio0.530.550.720.751.08
Price-to-Book (P/B) Ratio0.580.580.880.891.00
Price-to-Free Cash Flow (P/FCF) Ratio9.594.13-21.19-8.80-55.59
Price-to-Operating Cash Flow Ratio4.662.92235.88-16.6627.64
Price-to-Earnings Growth (PEG) Ratio1.80-0.04-0.31-0.061.04
Enterprise Value Multiple4.443.4322.2434.4518.04
Enterprise Value73.74B64.72B108.07B117.23B113.54B
EV to EBITDA4.443.4322.2434.4518.04
EV to Sales0.520.490.790.840.98
EV to Free Cash Flow9.443.67-23.07-9.94-50.64
EV to Operating Cash Flow4.592.59256.79-18.8225.18
Tangible Book Value Per Share8278.808152.556256.327216.637804.17
Shareholders’ Equity Per Share7791.897738.496046.127045.317787.50
Tax and Other Ratios
Effective Tax Rate0.04-0.03-0.02-0.16-1.40
Revenue Per Share8491.638227.607394.638376.077247.01
Net Income Per Share491.47538.86-387.00-266.90-57.67
Tax Burden0.860.871.321.162.40
Interest Burden0.860.767.273.10-0.21
Research & Development to Revenue0.030.020.050.060.03
SG&A to Revenue0.140.130.120.140.14
Stock-Based Compensation to Revenue0.000.000.000.00-0.00
Income Quality1.762.42-0.061.41-4.90

Currency in KRW